Dry Eye- Pam Theriot, OD

👁️ Dr. Pam Theriot discusses the tolerability of dry eye treatments! This review by Gupta et al., published in Clinical Ophthalmology (2024), examines the safety and tolerability profiles of both approved and investigational therapies for dry eye disease, providing a comprehensive overview of current treatment options and emerging innovations in clinical care. 🌟 🎥 Listen to this video to hear what Dr. Theriot has to say! 💼 Disclosures: Dr. Theriot has disclosures with Dompe, Lumenis, Bruder, Sun, Tarsus, NovaBay, Viatris, Scope, and Johnson & Johnson Vision. References: Gupta, P. K., Toyos, R., Sheppard, J. D., Toyos, M., Mah, F. S., Bird, B., … Higgins, D. (2024). Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies. Clinical Ophthalmology, 18, 2283–2302. https://doi.org/10.2147/OPTH.S465143